Important regulatory news last week included French pharma major Sanofi gaining approval from the US Food and Drug ...

Mpox has proven to be a major public threat since its resurgence globally during the COVID years. On August 14, the World ...

Spain is moving forward with a framework for medical cannabis usage after delays due to a general election. The draft ...

Opioid Use Disorder (OUD) is a chronic neurological disorder that is described as the consequences associated with repeated, ...

NHS England has proposed a phased rollout of Eli Lilly’s obesity injection Mounjaro (tirzepatide), prioritizing patients with ...

GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Early Access Programs (EAPs) and Named Patient Programs (NPPs) provide a pathway for patients with life-threatening ...

Shattuck Labs is reducing its workforce by 40%, bringing its employee count below 50, and discontinuing its SL-172154 program ...

Bristol Myers Squibb has received FDA approval for Opdivo (nivolumab) combined with chemotherapy as a perioperative treatment ...

The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...

The US Food and Drug Administration (FDA) yesterday released its fiscal year 2023 (FY23) Generic Drug User Fee Amendments ...